We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDS icon
751
Factset
FDS
$9.58B
$597K ﹤0.01%
2,230
+150
+7% +$38.5K
UNF icon
752
Unifirst Corp
UNF
$5.43B
$597K ﹤0.01%
2,961
+87
+3% +$17.6K
NDAQ icon
753
Nasdaq
NDAQ
$52.6B
$590K ﹤0.01%
16,569
+135
+0.8% +$4.6K
VLY icon
754
Valley National Bancorp
VLY
$7.95B
$580K ﹤0.01%
50,728
-14,392
-22% -$166K
SHOP icon
755
Shopify
SHOP
$167B
$575K ﹤0.01%
14,510
+620
+4% +$21K
REXR icon
756
Rexford Industrial Realty
REXR
$8.65B
$573K ﹤0.01%
12,563
-8,627
-41% -$399K
CHRW icon
757
C.H. Robinson
CHRW
$20.1B
$567K ﹤0.01%
7,254
-583
-7% -$46.4K
PAYC icon
758
Paycom
PAYC
$7.21B
$566K ﹤0.01%
2,143
-839
-28% -$199K
WAB icon
759
Wabtec
WAB
$50.6B
$565K ﹤0.01%
7,269
-1,291
-15% -$95.5K
TDOC icon
760
Teladoc Health
TDOC
$1.61B
$562K ﹤0.01%
6,719
+108
+2% +$8.22K
RGEN icon
761
Repligen
RGEN
$7.75B
$557K ﹤0.01%
6,022
+1,129
+23% +$94.8K
NGVT icon
762
Ingevity
NGVT
$2.61B
$556K ﹤0.01%
6,365
-1,447
-19% -$127K
MWA icon
763
Mueller Water Products
MWA
$3.96B
$554K ﹤0.01%
46,259
-4,945
-10% -$56.5K
VRTX icon
764
Vertex Pharmaceuticals
VRTX
$123B
$550K ﹤0.01%
2,515
-94
-4% -$19K
CFR icon
765
Cullen/Frost Bankers
CFR
$10.3B
$549K ﹤0.01%
5,636
-1,029
-15% -$95.6K
GH icon
766
Guardant Health
GH
$19.3B
$546K ﹤0.01%
6,999
+922
+15% +$66.4K
AXON
767
Axon Enterprise
AXON
$42.8B
$544K ﹤0.01%
7,438
-295
-4% -$18.7K
FIVN icon
768
FIVE9
FIVN
$2B
$544K ﹤0.01%
8,309
+1,046
+14% +$64K
MANT
769
DELISTED
Mantech International Corp
MANT
$542K ﹤0.01%
6,800
+178
+3% +$13.3K
SSD icon
770
Simpson Manufacturing
SSD
$8.19B
$539K ﹤0.01%
6,720
+393
+6% +$30.6K
SEIC icon
771
SEI Investments
SEIC
$12.2B
$537K ﹤0.01%
8,216
– –
WTM icon
772
White Mountains Insurance
WTM
$5.38B
$536K ﹤0.01%
481
-45
-9% -$49.1K
JBTM
773
JBT Marel
JBTM
$7.48B
$532K ﹤0.01%
4,730
+3,274
+225% +$351K
KHC icon
774
Kraft Heinz
KHC
$31.7B
$530K ﹤0.01%
16,549
-6,514
-28% -$197K
MTUM icon
775
iShares MSCI USA Momentum Factor ETF
MTUM
$25.2B
$530K ﹤0.01%
4,222
+29
+0.7% +$3.52K
29 30
31
32 33

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.